loadpatents
name:-0.014019966125488
name:-0.029841899871826
name:-0.00060510635375977
SIRCAR; Ila Patent Filings

SIRCAR; Ila

Patent Applications and Registrations

Patent applications and USPTO patent grants for SIRCAR; Ila.The latest application filed is for "inhibitors of alpha4 mediated cell adhesion".

Company Profile
0.28.12
  • SIRCAR; Ila - San Diego CA
  • Sircar, Ila - Clarks Summit PA
  • Sircar; Ila - Ann Arbor MI
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Inhibitors Of Alpha4 Mediated Cell Adhesion
App 20130289109 - KAWAGUCHI; Takayuki ;   et al.
2013-10-31
Inhibitors of .alpha..sub.4 mediated cell adhesion
Grant 8,501,809 - Kawaguchi , et al. August 6, 2
2013-08-06
Inhibitors Of Alpha4 Mediated Cell Adhesion
App 20110077299 - KAWAGUCHI; Takayuki ;   et al.
2011-03-31
Inhibitors of .alpha..sub.4 mediated cell adhesion
Grant 7,872,151 - Kawaguchi , et al. January 18, 2
2011-01-18
Inhibitors Of Alpha4 Mediated Cell Adhesion
App 20100113820 - KAWAGUCHI; Takayuki ;   et al.
2010-05-06
Inhibitors of .alpha..sub.4 mediated cell adhesion
Grant 7,671,090 - Kawaguchi , et al. March 2, 2
2010-03-02
Inhibitors Of Alpha4 Mediated Cell Adhesion
App 20090111879 - KAWAGUCHI; Takayuki ;   et al.
2009-04-30
Inhibitors of alpha4 mediated cell adhesion
Grant 7,456,217 - Kawaguchi , et al. November 25, 2
2008-11-25
Inhibitors of .alpha..sub.1 .beta..sub.2 integrin mediated cell adhesion
Grant 7,375,128 - Sircar , et al. May 20, 2
2008-05-20
Inhibitors of .alpha..sub.L.beta..sub.2 mediated cell adhesion
Grant 7,342,012 - Sircar , et al. March 11, 2
2008-03-11
Inhibitors of alpha4 mediated cell adhesion
App 20050282900 - Kawaguchi, Takayuki ;   et al.
2005-12-22
Inhibitors of alphaLbeta2 mediated cell adhesion
App 20050148602 - Sircar, Ila ;   et al.
2005-07-07
Inhibitors of .alpha.L.beta.2 mediated cell adhesion
Grant 6,897,225 - Sircar , et al. May 24, 2
2005-05-24
Inhibitors of .alpha.4 mediated cell adhesion
Grant 6,855,843 - Sircar , et al. February 15, 2
2005-02-15
Inhibitors of .alpha.L.beta.2 mediated cell adhesion
Grant 6,699,888 - Sircar , et al. March 2, 2
2004-03-02
Inhibitors of alpha l beta 2 mediated cell adhesion
App 20030225138 - Sircar, Ila ;   et al.
2003-12-04
Inhibitors of alpha4 mediated cell adhesion
App 20030191118 - Sircar, Ila ;   et al.
2003-10-09
Inhibitors of .alpha.4 mediated cell adhesion
Grant 6,521,666 - Sircar , et al. February 18, 2
2003-02-18
Thiadiazole antifungal agents
App 20020002193 - Yu, Dingwei Tim ;   et al.
2002-01-03
Oxadiazole antifungal agents
Grant 6,277,873 - Yu , et al. August 21, 2
2001-08-21
Novel class of piperazino substituted thiazoles
App 20010000512 - Yu, Dingwei Tim ;   et al.
2001-04-26
Novel class of thiomorpholino substituted thiazoles
App 20010000177 - Yu, Dingwei Tim ;   et al.
2001-04-05
Pyridyl Substituted Thiazoles
App 20010000178 - Yu, Dingwei Tim ;   et al.
2001-04-05
Imidazole and 1,2,4-triazole derivatives with angiotensin II antagonist properties
Grant 5,389,661 - Sircar , et al. February 14, 1
1995-02-14
Imidazole with angiotensin II antagonist properties
Grant 5,322,950 - Sircar , et al. June 21, 1
1994-06-21
Acat inhibitors for treating hypocholesterolemia
Grant 5,153,226 - Chucholowski , et al. October 6, 1
1992-10-06
3-5-ditertiarybutylphenyl-4-hydroxymethylidene derivatives of 1,3-dihydro-2H-indole-2-ones as antiinflammatory agents
Grant 5,124,347 - Connor , et al. June 23, 1
1992-06-23
Novel renin inhibiting peptides
Grant 5,071,837 - Doherty , et al. December 10, 1
1991-12-10
Renin inhibitors, method for using them, and compositions containing them
Grant 5,063,207 - Doherty , et al. November 5, 1
1991-11-05
Diol-containing renin inhibitors
Grant 5,036,053 - Himmelsbach , et al. July 30, 1
1991-07-30
3-aminopropoxyaryl derivatives having cardiotonic and antihypertensive use and compositions thereof
Grant 4,980,351 - Barth , et al. December 25, 1
1990-12-25
Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2H)-pyridazinones and 6-(substituted) phenyl-3(2H)-pyridazinones
Grant 4,734,415 - Sircar , et al. * March 29, 1
1988-03-29
Substituted 2,2-dimethyl-5-phenoxypentanoic acid benzamides as anti-arteriosclerotic agents and method
Grant 4,554,282 - Sircar , et al. November 19, 1
1985-11-19
4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones and 6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones
Grant 4,521,416 - Sircar , et al. June 4, 1
1985-06-04
Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
Grant 4,404,203 - Sircar September 13, 1
1983-09-13
4-(Substituted)-.alpha., .alpha.-dimethyl-1-piperazine pentanoic acids and derivatives as anti-arteriosclerotic agents and method
Grant 4,397,855 - Sircar August 9, 1
1983-08-09
Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
Grant 4,397,854 - Sircar August 9, 1
1983-08-09
Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones
Grant 4,353,905 - Sircar , et al. October 12, 1
1982-10-12
Anti-arteriosclerotic agents
Grant 4,351,950 - Sircar September 28, 1
1982-09-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed